Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-04 9:02 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
360,540 | $7.9634 | $2,871,124 | 2,232,918 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-07 4:46 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
126,981 | $5.6 | $711,094 | 1,522,114 (Direct) |
View |
| 2023-03-02 Sale(A) |
2024-02-22 4:15 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
33,047 | $8.78 | $290,153 | 982,671 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 4:27 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
32,750 | $8.94 | $292,785 | 982,968 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-26 5:22 pm |
ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director |
79,645 | $5.6 | $446,012 | 0 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-04 4:11 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
9,068 | $12.01 | $108,907 | 879,395 (Direct) |
View |
| 2021-05-11 Purchase |
2021-05-12 4:32 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
5,125 | $10.71 | $54,891 | 13,453 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-07-02 Option Award |
2025-07-07 9:46 pm |
2026-07-02 2035-07-02 |
Pelthos Therapeutics Inc. | PTHS | Greenleaf Peter Director |
103,118 | $0 | 103,118 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 9:02 pm |
N/A 2035-02-28 |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
1,068,406 | $0 | 2,232,918 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:25 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
661,538 | $0 | 1,649,095 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 4:27 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
667,407 | $0 | 982,968 (Direct) |
View |
| 2022-03-22 Other |
2022-03-22 5:12 pm |
N/A N/A |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director |
105,034 | $0 | 105,034 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:11 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
874,728 | $0 | 879,395 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 6:02 pm |
N/A 2032-01-26 |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director |
114,347 | $3.66 | 250,119 (Direct) |
View |
| 2022-01-27 Exercise |
2022-01-31 6:02 pm |
N/A 2023-01-27 |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director |
10,246 | $0 | 250,119 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 6:02 pm |
N/A 2023-01-27 |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director |
20,492 | $0 | 250,119 (Direct) |
View |
| 2021-08-06 Exercise |
2021-08-10 6:17 pm |
N/A 2022-08-01 |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director |
35,000 | $0 | 112,288 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:22 pm |
N/A N/A |
ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director |
25,452 | $4.42 | 128,187 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:22 pm |
N/A 2031-06-10 |
ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director |
48,542 | $0 | 128,187 (Direct) |
View |
Ownership |
2021-01-04 5:53 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
0 | $0 | 2,838,128 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-11 5:03 pm |
N/A 2022-08-01 |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director |
35,000 | $0 | 112,288 (Direct) |
View |